MKI67 and central nervous system cancer: The Ki-67 LI of low-grade glioma patients was 0.05 (0.02-0.17) and that of high-grade glioma patients was 0.26 (0.02-0.63), to show the significant differences between the two groups of the patients (P < 0.001, Table 2).